ClearPoint Neuro Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2008
Revenue	23.96	20.55	16.3	12.83	11.22	Upgrade
Revenue Growth (YoY)	16.56%	26.09%	27.05%	14.37%	52.54%	Upgrade
Cost of Revenue	10.34	7.02	5.18	3.71	3.94	Upgrade
Gross Profit	13.61	13.53	11.12	9.12	7.28	Upgrade
Selling, General & Admin	24.35	18.97	15.22	10.65	9.06	Upgrade
Research & Development	11.71	10.89	9.28	4.69	2.81	Upgrade
Operating Expenses	36.06	29.86	24.5	15.34	11.87	Upgrade
Operating Income	-22.45	-16.33	-13.37	-6.22	-4.59	Upgrade
Interest Expense / Income	-0.39	0.08	0.97	1.44	0.96	Upgrade
Other Expense / Income	0.03	0.02	0.06	-0.88	-0.01	Upgrade
Pretax Income	-22.09	-16.44	-14.41	-6.78	-5.54	Upgrade
Net Income	-22.09	-16.44	-14.41	-6.78	-5.54	Upgrade
Shares Outstanding (Basic)	25	24	21	16	13	Upgrade
Shares Outstanding (Diluted)	25	24	21	16	13	Upgrade
Shares Change	1.75%	16.63%	30.82%	20.48%	20.38%	Upgrade
EPS (Basic)	-0.90	-0.68	-0.69	-0.43	-0.42	Upgrade
EPS (Diluted)	-0.90	-0.68	-0.69	-0.43	-0.42	Upgrade
Free Cash Flow	-14.77	-17.31	-12.87	-8.29	-3.01	Upgrade
Free Cash Flow Per Share	-0.60	-0.72	-0.62	-0.52	-0.23	Upgrade
Gross Margin	56.83%	65.84%	68.24%	71.09%	64.86%	Upgrade
Operating Margin	-93.70%	-79.47%	-82.05%	-48.48%	-40.96%	Upgrade
Profit Margin	-92.21%	-79.97%	-88.41%	-52.86%	-49.39%	Upgrade
Free Cash Flow Margin	-61.66%	-84.24%	-78.93%	-64.61%	-26.83%	Upgrade
EBITDA	-21.02	-15.58	-12.75	-4.79	-4.33	Upgrade
EBITDA Margin	-87.74%	-75.80%	-78.19%	-37.32%	-38.64%	Upgrade
Depreciation & Amortization	1.46	0.78	0.69	0.55	0.25	Upgrade
EBIT	-22.48	-16.35	-13.44	-5.34	-4.59	Upgrade
EBIT Margin	-93.82%	-79.58%	-82.44%	-41.61%	-40.88%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).